Breaks Categories: News

WednesdayAug 23, 2017 9:17 am

NetworkNewsBreaks – PotNetwork Holdings, Inc. (POTN) Adds Dr. David Feldbaum to Newly Formed Advisory Board

PotNetwork Holdings, Inc. (OTC: POTN) this morning announced the addition of Dr. David M. Feldbaum MD, FACS to its board of advisors. Feldbaum is certified in vascular surgery by the American Board of Surgery, having completed a surgical residency at Montefiore Medical Center/Albert Einstein College of Medicine in New York City. “We are very pleased to have Dr. Feldbaum join our growing team of advisors,” Maria Gomez, regional vice president of sales for PotNetwork subsidiary Diamond CBD, stated in the news release. “We expect that his experience and wisdom will strengthen the Company’s position in the industry as we target…

Continue Reading

TuesdayAug 22, 2017 12:06 pm

NetworkNewsBreaks – Inpixon (NASDAQ: INPX) Enters New Partnership with GTRI to Boost Physical Cybersecurity Line; Shares Weighted by Q2 Results

Inpixon (NASDAQ: INPX) this morning said it has entered into a partnership with GTRI, an IT consulting and services company, to render comprehensive three-dimensional physical cybersecurity solutions, including Inpixon Indoor Positioning Analytics (IPA) Security Dome. Per the agreement, GTRI will leverage the company’s technology to enable government organizations and enterprises to identify any potential exposures while preserving security and compliance standards. Shares of Inpixon are down 14% mid-day, likely moving on the company’s second-quarter financial performance, reported yesterday. Revenues increased $1.8 million to $15.1 million, compared to the second quarter of last year; Inpixon’s non-GAAP net loss widened to ($1.89)…

Continue Reading

TuesdayAug 22, 2017 9:42 am

NetworkNewsBreaks – HighCom Global Security, Inc. (HCGS) Provides Update on Key Corporate Milestones

Leading security solutions provider HighCom Global Security, Inc. (OTC: HCGS) this morning offered an update on key milestones the company has achieved in its product technology this year. These include the February launch of four new hard armor models through its HighCom Armor Solutions, Inc. division and the July NIJ approval of two additional armor models, including a Level IIIa elite, lightweight, high-performance soft armor panel and a Level III++, multi-curve, hard armor ballistic plate. “The addition of these new products increases HighCom Armor's ability to equip our customers with high quality, in demand armor that has been the cornerstone…

Continue Reading

TuesdayAug 22, 2017 9:18 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) Enters Letter of Intent to Acquire Dr. FeelGood

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced that it has signed a letter of intent to acquire Dr. FeelGood, a profitable Phoenix-based medical marijuana company with plans to develop a proprietary delivery and ordering technology. Per the terms of the agreement, SinglePoint will acquire 51 percent of Dr. FeelGood through a combination of cash and stock, adding an additional revenue stream to SinglePoint while solidifying its acquisition-based revenue strategy. “This acquisition is right in our wheel house,” Greg Lambrecht, CEO of SinglePoint, stated in the news release. “I previously took a distribution company public on the NASDAQ…

Continue Reading

MondayAug 21, 2017 4:09 pm

NetworkNewsBreaks – Cardiome Pharma Corp. (NASDAQ: CRME) Shares Sink on Disappointing Regulatory Feedback

Shares of Cardiome Pharma Corp. (NASDAQ: CRME) are down 33% near market close, though pulling from a new 52-week low reached earlier in the day’s trading session. Cardiome this morning said the U.S. FDA has advised that the company’s proposed data package would not would not be sufficient to support a resubmission of the BRINAVESS New Drug Application (NDA). BRINAVESS is Cardiome’s antiarrhythmic drug for the rapid conversion of recent onset atrial fibrillation (AF). “In our most recent communication with the FDA, we proposed resubmission of the NDA based upon the original file and six years of accumulated safety data…

Continue Reading

MondayAug 21, 2017 11:09 am

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Attending Southern California Investment Forum and MoneyShow San Francisco

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that it will attend the Southern California Investment Forum, which is set to take place on August 24, 2017, at Morton’s Steakhouse in San Francisco. Additionally, the company will attend the MoneyShow Conference at the Marriott Marquis in San Francisco, taking place August 24-26, 2017. “I am delighted that CIIX has been invited to attend the Southern California Investment Forum and MoneyShow San Francisco,” Warren Wang, CEO and founder of CIIX, stated in the news release. “MoneyShow hosts one of the most well-known investor conferences, which attracts traders and financial…

Continue Reading

MondayAug 21, 2017 9:30 am

NetworkNewsBreaks – Global Payout, Inc. (GOHE) Subsidiary Finalizes Business Development Agreement with Pot Saver

Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that its majority owned subsidiary, MoneyTrac Technology, Inc., has finalized a business development agreement with Pot Saver, a Southern California-based community periodical providing listings on discounted cannabis-related products for local dispensaries and shops. “With the medical and recreational cannabis industry growing at an unprecedented rate in California, we are determined to be conscious of the multiple opportunities that currently exist, or that we can create for MoneyTrac to further expand its brand throughout the industry as well as tap into every available revenue source possible,” Vanessa Luna, COO of…

Continue Reading

MondayAug 21, 2017 9:09 am

NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Reports Financial Results for Quarter Ended June 30, 2017

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced its financial results for the quarter ended June 30, 2017. “During the quarter, we secured an IP licensing agreement from the University of South Florida addressing a potential treatment for Alzheimer’s disease,” Ram Mukunda, CEO of IGC, stated in the news release. “This patent filing claims discovery of a new pathway: low doses of THC bind to amyloid beta plaques and prevent those plaques from aggregating on neurons, which is what occurs in Alzheimer’s disease and causes cognitive…

Continue Reading

FridayAug 18, 2017 10:56 am

NetworkNewsBreaks – Diana Containerships Inc. (NASDAQ: DCIX) Enters Time Charter Contract with CMA CGM

Global shipping company Diana Containerships Inc. (NASDAQ: DCIX), through a separate wholly-owned subsidiary, this morning announced that it has entered into a time charter contract with CMA CGM, Marseille, for one of its Panamax container vessels, the m/v Domingo. The charter will commence on September 15, 2017, and will continue for a period of between eight and 11 months. The gross charter rate of this contract is $8,500 per day, minus a 3.5 percent commission paid to third parties. Diana expects to generate approximately $2.04 million of gross revenue for the minimum scheduled period of the time charter. Diana’s fleet…

Continue Reading

FridayAug 18, 2017 9:11 am

NetworkNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Enters Consulting Agreement with Creative Capital Media

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced its entry into a consulting agreement with Creative Capital Media (“CCM”). Moving forward, CCM, a media and advertising consultancy, will provide communication and awareness services to InMed in North America. To view the full press release, visit http://nnw.fm/Ad3jv About InMed InMed is a preclinical stage biopharmaceutical company specializing in the research and development of novel, cannabinoid-based prescription drug therapies utilizing novel drug delivery systems. InMed conducts research, discovery, preclinical, clinical, regulatory, manufacturing and commercial development activities for its product candidates. InMed's proprietary bioinformatics database assessment tool,…

Continue Reading